Novel Therapies Show Promise in Mantle Cell Lymphoma
New combination strategies are required for heterogeneity of mantle cell lymphoma (MCL), in order to improve outcomes.
Read More
Immune Checkpoint Inhibitors in Lymphoma Spark Enthusiasm and Questions
Clinical evaluation suggests a role for immune checkpoint inhibition in the treatment of patients with lymphomas, but early success has also raised many questions.
